GALZIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Galzin, and when can generic versions of Galzin launch?
Galzin is a drug marketed by Teva and is included in one NDA.
The generic ingredient in GALZIN is zinc acetate. There are thirty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the zinc acetate profile page.
Summary for GALZIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for GALZIN |
What excipients (inactive ingredients) are in GALZIN? | GALZIN excipients list |
DailyMed Link: | GALZIN at DailyMed |
Recent Clinical Trials for GALZIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
American Lung Association | Phase 2 |
Johns Hopkins University | Phase 2 |
National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
Pharmacology for GALZIN
Drug Class | Copper Absorption Inhibitor |
Physiological Effect | Decreased Copper Ion Absorption |
Anatomical Therapeutic Chemical (ATC) Classes for GALZIN
US Patents and Regulatory Information for GALZIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | GALZIN | zinc acetate | CAPSULE;ORAL | 020458-001 | Jan 28, 1997 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | GALZIN | zinc acetate | CAPSULE;ORAL | 020458-002 | Jan 28, 1997 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |